Xianggen Wu Selected Research

Xianggen Wu Research Topics

Disease

5	Burns 03/2024 - 03/2020
5	Keratitis 02/2021 - 08/2012
4	Eye Diseases (Eye Disease) 04/2024 - 12/2019
4	Dry Eye Syndromes (Dry Eye Syndrome) 04/2024 - 12/2021
3	Inflammation (Inflammations) 10/2022 - 10/2011
2	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2013
2	Wounds and Injuries (Trauma) 01/2021 - 07/2020
2	Eye Infections 01/2021 - 10/2020
2	Infections 08/2012 - 04/2012
2	Endophthalmitis (Ophthalmia) 04/2012 - 10/2011
1	Corneal Opacity 03/2024
1	Corneal Neovascularization 03/2024
1	Hyperlipidemias (Hyperlipidemia) 10/2023
1	Liver Diseases (Liver Disease) 11/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022
1	Hypoxia (Hypoxemia) 10/2022
1	Cicatrix (Scar) 01/2022
1	Ischemia 01/2022
1	Pancreatitis 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Reperfusion Injury 01/2022
1	Bacterial Infections (Bacterial Infection) 02/2021
1	Glaucoma 01/2021
1	Neoplasms (Cancer) 01/2020
1	Corneal Injuries 12/2019
1	Ulcerative Colitis 01/2019
1	Blindness (Hysterical Blindness) 04/2013
1	Edema (Dropsy) 12/2012

Drug/Important Bio-Agent (IBA)

12	Ophthalmic Solutions (Eye Drops)IBA 04/2024 - 04/2012
5	AlkaliesIBA 03/2024 - 03/2020
5	Glycyrrhizic Acid (Glycyrrhizin)IBA 10/2023 - 01/2021
5	MicellesIBA 01/2022 - 12/2019
4	Therapeutic UsesIBA 03/2024 - 10/2011
4	SolutionsIBA 12/2021 - 04/2012
3	HMGB1 Protein (HMG1)IBA 04/2024 - 01/2021
3	SaltsIBA 10/2023 - 04/2012
3	Levofloxacin (Levaquin)FDA Link 04/2020 - 04/2012
2	empagliflozinIBA 03/2023 - 01/2022
2	CytokinesIBA 10/2022 - 07/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2013
2	Gemifloxacin (Factive)FDA Link 08/2012 - 04/2012
2	FluoroquinolonesIBA 08/2012 - 04/2012
1	cytisineIBA 04/2024
1	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 04/2024
1	HydrogelsIBA 03/2024
1	Tyrosine Kinase InhibitorsIBA 03/2024
1	Imatinib Mesylate (Gleevec)FDA Link 03/2024
1	icariinIBA 10/2023
1	oxidized low density lipoproteinIBA 10/2023
1	Triglycerides (Triacylglycerol)IBA 10/2023
1	LDL CholesterolIBA 10/2023
1	CholesterolIBA 10/2023
1	PhytochemicalsIBA 01/2023
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2022
1	CollagenIBA 11/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2022
1	CaprolactamIBA 01/2022
1	InflammasomesIBA 01/2022
1	polyvinyl acetateIBA 01/2022
1	pterostilbeneIBA 01/2022
1	MelatoninIBA 01/2022
1	PolyvinylsIBA 01/2022
1	PolymersIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Netrin-1IBA 01/2022
1	naringeninIBA 12/2021
1	rebamipideIBA 12/2021
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2021
1	Rose BengalIBA 12/2021
1	xanthan gum (xanthan)FDA LinkGeneric 02/2021
1	Linezolid (Zyvox)FDA Link 02/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2021
1	hesperetinIBA 01/2021
1	Nimodipine (Modus)FDA LinkGeneric 01/2021
1	rebaudioside AIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	SuspensionsIBA 01/2021
1	Indomethacin (Indometacin)FDA LinkGeneric 07/2020
1	GelsIBA 04/2020
1	Photosensitizing Agents (Photosensitizers)IBA 01/2020
1	Liposomes (Liposome)IBA 01/2020
1	Lipid Bilayers (Lipid Bilayer)IBA 01/2020
1	polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymerIBA 12/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2019
1	balofloxacin (Q 35)IBA 08/2014
1	Multidrug Resistance-Associated ProteinsIBA 11/2013
1	major vault proteinIBA 11/2013
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2013
1	3-hydroxycholest-7-ene-14-carbaldehydeIBA 11/2013
1	Retinal Pigments (Pigments, Visual)IBA 11/2013

Therapy/Procedure

3	Topical Administration 03/2024 - 12/2021
3	Oral Administration 10/2022 - 01/2019
2	Transplantation 10/2022 - 01/2022
1	Ligation 11/2022
1	Therapeutics 01/2020
1	Ophthalmic Administration 12/2019
1	Corneal Transplantation (Keratoplasty) 04/2013